Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma.

Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33909691

about

Annexin II up-regulates cellular levels of p11 protein by a post-translational mechanisms Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress NOX1 supports the metabolic remodeling of HepG2 cells Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line.Immunological approach to hepatocellular carcinoma.Identification of differentially expressed genes in clear cell renal cell carcinoma by analysis of full-length enriched cDNA library.Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells.Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells.Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity.Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.Annexin A2 heterotetramer: structure and function Annexin II represents metastatic potential in clear-cell renal cell carcinoma.Effect of shRNA mediated down-regulation of Annexin A2 on biological behavior of human lung adencarcinoma cells A549.Annexin II overexpression predicts rapid recurrence after surgery in pancreatic cancer patients undergoing gemcitabine-adjuvant chemotherapy.Annexin A2 is a novel RNA-binding protein.Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.Effect of ethanol on p36 protein kinase substrate and insulin receptor substrate 1 expression and tyrosyl phosphorylation in human hepatocellular carcinoma cells.Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma.Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site.Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA - effects on NS5B catalysis and allosteric inhibition.

P2860

Q24534144-8E3FD337-B63B-49C4-8311-BB0F56FA289D Q24562001-B5F66596-908E-4378-80D2-8A969B1315D3 Q24564032-D52AFE37-34A7-441B-A815-6322364DC40E Q28344346-7C5E4364-494C-4F3D-B244-B839833F7654 Q28544991-DCA0C94B-FD74-4A05-B284-B2758129B358 Q31160381-1ADD33E3-39D9-479A-B480-DF454E92893D Q32147095-75AEFF66-AF8E-45D9-993C-590BA2DB0478 Q33232894-34040AEB-6FA8-4F40-8BF6-EBD67F8AF7C8 Q33249524-E992642F-3B78-4571-9644-D514AB3B1FDA Q34945896-67716516-30E0-49DD-9E32-7EAE820AB1A1 Q35531212-60958A77-13E0-4B93-8BC1-B5C5FFAB99A8 Q35928337-E88D7B6A-7286-40E8-A871-65290BF8F766 Q36636344-DE35048A-53B9-43D0-AC7D-D4027849ADD8 Q36790362-3B846D01-44AB-4B04-957F-BFFDE393BE34 Q37287432-BC496B91-3898-4764-AA4D-5F1235ECBA1F Q39521584-98BE9E13-35E6-493A-9A41-741C624B6143 Q39949416-E541C4D6-8B02-4701-A9DA-3C61001E7082 Q40607858-1E27F49D-31F2-4290-A96E-7ADCB3F739C6 Q40763250-37C49E3F-A969-445A-9627-624F2937BA17 Q41307496-0F6E6AB8-DA7A-4804-B213-A9A6BBCBEE08 Q41356692-207FBE9E-815D-4731-9D92-C0AADD3977C4 Q42486896-0C4DFA3E-2802-4595-99BE-289B5B6FA812 Q43559647-E82486EF-D75E-411E-B71B-6B5AA60071F5 Q47098153-C9845AE6-C061-48DC-B515-87AE3876E05B

P2860

Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33909691

description

1990 nî lūn-bûn

@nan

1990 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Enhanced expression of the pro ...... uman hepatocellular carcinoma.

@ast

Enhanced expression of the pro ...... uman hepatocellular carcinoma.

@en

type

label

Enhanced expression of the pro ...... uman hepatocellular carcinoma.

@ast

Enhanced expression of the pro ...... uman hepatocellular carcinoma.

@en

prefLabel

Enhanced expression of the pro ...... uman hepatocellular carcinoma.

@ast

Enhanced expression of the pro ...... uman hepatocellular carcinoma.

@en

P1433

Q33909691-803D57AE-1FEA-473F-8577-AF7EC9259F0B

P1476

Q33909691-202F1311-F53B-4A1E-9278-B0FC793C1FA4

P2093

Q33909691-11E5B2A9-73A9-46C9-9C65-076285968F57

Q33909691-8331B865-FEA2-430C-82D8-F572BE725F4C

Q33909691-8E038003-7E7A-47FD-B772-D84148917393

Q33909691-B13F9160-2DC0-40A7-B9F2-729C70D21A85

Q33909691-D6C12901-25EF-4EF8-A60B-C40971CFBB8F

Q33909691-FBA873E8-68F4-49B4-883C-3A633950264C

P2860

Q33909691-00337EEC-970B-476E-B862-E3810AE2E6BB

Q33909691-02B42679-E39B-4F6A-BE9C-EA51A1D97196

Q33909691-0514BA67-A28A-472E-8D7D-9CF862F1DA1A

Q33909691-10CAB574-0BB7-4BE0-880A-14527C679AD0

Q33909691-1F1C2E4A-6223-415F-AF3F-B86A94A265AD

Q33909691-2E60FCF2-8826-4FAF-852C-692CB7007772

Q33909691-31B672DC-641A-4060-AA86-E4E5D6C19501

Q33909691-527AA35C-B641-49D8-B8AA-580176BBD79A

Q33909691-5BEC0A15-E6E1-4C9D-B1D7-438B0E52E8CB

Q33909691-5DA89206-9C55-401F-AAAC-F52843FD6145

P304

Q33909691-39C25C21-66C7-4BC4-95D9-5347A94B2218

P31

Q33909691-D514661D-8FC4-46DE-9EC8-EA40319CE816

P356

Q33909691-EA08AC61-0523-42D8-917C-3CE13C7E4BE7

P407

Q33909691-F9E271E1-F2D1-4248-A0C9-49445B6F6008

P433

Q33909691-AC357231-619E-4B02-AF11-4F1A0E1256AD

P478

Q33909691-170C7539-517D-40FC-87AE-E362A0898874

P577

Q33909691-1B008A5C-0B81-4D53-9885-2C2D14B7E006

P698

Q33909691-AB3994FC-CE6D-4907-9E68-56CBAEC1312D

P932

Q33909691-7C3DBDC0-2364-4569-86B5-FA744EC00C61

P356

P1433

Molecular and Cellular Biology

P1476

Enhanced expression of the pro ...... uman hepatocellular carcinoma.

@en

P2093

H Takahashi

http://www.w3.org/2001/XMLSchema#string

J Wands

http://www.w3.org/2001/XMLSchema#string

K Galvin

http://www.w3.org/2001/XMLSchema#string

M Frohlich

http://www.w3.org/2001/XMLSchema#string

M Ozturk

http://www.w3.org/2001/XMLSchema#string

P Motté

http://www.w3.org/2001/XMLSchema#string

P2860

Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

A comprehensive set of sequence analysis programs for the VAX

Five distinct calcium and phospholipid binding proteins share homology with lipocortin I

Diversity in the lipocortin/calpactin family

Aggregation of chromaffin granules by calpactin at micromolar levels of calcium.

Cell-surface changes associated with transformation of human hepatocytes to the malignant phenotype

Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides.

First-strand cDNA synthesis primed with oligo(dT).

Two related but distinct forms of the Mr 36,000 tyrosine kinase substrate (calpactin) that interact with phospholipid and actin in a Ca2+-dependent manner

P304

3216-3223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.10.6.3216

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

1990-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2160596

http://www.w3.org/2001/XMLSchema#string

P932

360686

http://www.w3.org/2001/XMLSchema#string